| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Pulmonary Division, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada
In the last decade, the ability of neutrophils to generate proinflammatory cytokines has become firmly established. Because neutrophils typically infiltrate inflammatory sites in large numbers, they could significantly contribute to the cytokine environment and even represent a substantial source of cytokines in chronic inflammatory disorders in which they predominate over other cell types. To date, however, most studies have focused on identifying which mediators are produced by neutrophils, as opposed to elucidating the molecular bases underlying this process. We previously showed that most stimuli of cytokine production in neutrophils also activate NF-
B in these cells. In this report, we turned our attention to another transcription factor that plays a central role in inflammation, AP-1. Among Jun/Fos proteins, only JunD and c-Fos are abundantly expressed in neutrophils, and they are mainly cytoplasmic. Both the cellular levels and distribution of the Jun/Fos proteins remain unaffected by various neutrophil stimuli, including those that are known to increase the corresponding mRNA transcripts. Similarly, c-Jun N-terminal kinase (JNK) 1 is overwhelmingly cytoplasmic in neutrophils and does not translocate to the nucleus upon cell activation. Although JNK is not activatable under most circumstances, specific conditions do allow its phosphorylation in response to TNF. However, no experimental condition (even those leading to JNK activation) resulted in the induction of genuine AP-1 complexes in neutrophils. Accordingly, the potent JNK inhibitor, SP 600125, failed to inhibit inflammatory cytokine gene expression in neutrophils. Collectively, our findings strongly suggest that the JNK/AP-1 signaling pathway has little or no impact on the generation of inflammatory mediators in neutrophils.
This article has been cited by other articles:
|
|
 |
|
  A. Cloutier, C. Guindi, P. Larivee, C. M. Dubois, A. Amrani, and P. P. McDonald Inflammatory Cytokine Production by Human Neutrophils Involves C/EBP Transcription Factors J. Immunol., January 1, 2009; 182(1): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Kogut, K. J. Genovese, Haiqi He, and P. Kaiser Flagellin and lipopolysaccharide up-regulation of IL-6 and CXCLi2 gene expression in chicken heterophils is mediated by ERK1/2-dependent activation of AP-1 and NF-{kappa}B signaling pathways Innate Immunity, August 1, 2008; 14(4): 213 - 222. [Abstract] [PDF]
|
|
|
|
|
|
W. Sukhumavasi, C. E. Egan, and E. Y. Denkers Mouse Neutrophils Require JNK2 MAPK for Toxoplasma gondii-Induced IL-12p40 and CCL2/MCP-1 Release J. Immunol., September 15, 2007; 179(6): 3570 - 3577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tamassia, V. Le Moigne, F. Calzetti, M. Donini, S. Gasperini, T. Ear, A. Cloutier, F. O. Martinez, M. Fabbri, M. Locati, et al. The MYD88-Independent Pathway Is Not Mobilized in Human Neutrophils Stimulated via TLR4 J. Immunol., June 1, 2007; 178(11): 7344 - 7356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cloutier, T. Ear, E. Blais-Charron, C. M. Dubois, and P. P. McDonald Differential involvement of NF-{kappa}B and MAP kinase pathways in the generation of inflammatory cytokines by human neutrophils J. Leukoc. Biol., February 1, 2007; 81(2): 567 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Bennett c-Jun N-terminal kinase-dependent mechanisms in respiratory disease. Eur. Respir. J., September 1, 2006; 28(3): 651 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jozsef, T. Khreiss, D. El Kebir, and J. G. Filep Activation of TLR-9 Induces IL-8 Secretion through Peroxynitrite Signaling in Human Neutrophils J. Immunol., January 15, 2006; 176(2): 1195 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ear, A. Cloutier, and P. P. McDonald Constitutive Nuclear Expression of the I{kappa}B Kinase Complex and Its Activation in Human Neutrophils J. Immunol., August 1, 2005; 175(3): 1834 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Fichorova, F. Zhou, V. Ratnam, V. Atanassova, S. Jiang, N. Strick, and A. R. Neurath Anti-Human Immunodeficiency Virus Type 1 Microbicide Cellulose Acetate 1,2-Benzenedicarboxylate in a Human In Vitro Model of Vaginal Inflammation Antimicrob. Agents Chemother., January 1, 2005; 49(1): 323 - 335. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
